Skip to content
CancerIndex

Publication

Innate immune dysregulation in multiple myeloma: molecular basis and mechanistic interventions.

Gang Wang, Hanlin Gao, Tianyi Xie, Fuming Zi

International immunopharmacologySep 15, 2026PMID 42314557doi:10.1016/j.intimp.2026.116996 Journal ArticleReviewpubmedProvenance
Source
PubMed
Retrieved
Sep 30, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260930-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

BACKGROUND: Multiple myeloma (MM) is a malignant clonal disorder originating from bone marrow plasma cells. Although the introduction of proteasome inhibitors, immunomodulatory agents, monoclonal antibodies, and cellular immunotherapies has markedly prolonged patient survival, relapse and drug…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.